Wegener's granulomatosis

Rheum Dis Clin North Am. 1995 Nov;21(4):949-86.


To manage Wegener's granulomatosis (WG) effectively, the clinician must establish the diagnosis without delay, recognize variability in clinical course and severity, critically monitor disease activity, and anticipate disease-related and treatment-related morbidity. These issues represent the focus of approach to the diagnosis and treatment of WG.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Biopsy
  • Granulomatosis with Polyangiitis* / diagnosis
  • Granulomatosis with Polyangiitis* / pathology
  • Granulomatosis with Polyangiitis* / therapy
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Immunotherapy
  • Prevalence
  • Tomography, X-Ray Computed


  • Antineoplastic Agents
  • Immunosuppressive Agents